News

7 April

Governments must ensure Big Pharma’s expansion in Africa doesn’t impede generics supply

3 March

New materials help assess medicines policies and interventions

24 February

A new (and improved) model to regulate pharmaceutical promotion

12 February

Enhancing accountability in the medicines market: The Medicines Transparency Alliance

31 January

Bayer CEO's callous comments highlight failure of current biomedical innovation model

31 January

Leaks and Lies: Pharma’s strategy to derail South Africa’s intellectual property reforms exposed

30 January

Selected R&D demonstration projects disappointing: Innovation models with new incentive mechanisms needed

23 January

Regulation critical to clinical trials data transparency in Europe

25 November

When politicians go to the movies

9 August

True clinical trials transparency? Not quite, EFPIA.

6 August

Conference contemplations: ‘Pharmaceuticals and global health – inequalities and innovation in the 21st century’

21 June

Good week for access to affordable medicines

10 June

Despite concrete steps forward, the ENVI vote on clinical trials regulation falls short on transparency

15 May

Bracing for another delay – open innovation at the WHO?

2 December

EU Policy Opportunities in Biomedical Innovation and the Public Good

13 October

Statement on Medicines Patent Pool

2 August

Public Event on EU-MERCOSUR in Buenos Aires

15 July

Study provides recommendations on European Medicines Agency's communication on medicines

14 July

The Diagnosis of Childhood Bipolar Disease has led to Catastrophic Consequences

12 July

DG Trade State of Play reveals EU's ambitions for IP protection in FTAs

30 June

TRIPS-Plus IP demands from EU could halt South American trade deal

23 June

EU Mercosur Trade Negotiations in July

23 June

HAI Europe’s participation at the “Ad hoc meeting – Bilateral trade negotiations: State of Play”

22 June

Conflicts of interest at the European Medicines Agency (EMA) and the need for a review of staff regulations

21 June

Submission to the Consultative Expert Working Group (CEWG) on alternative financing

24 May

HAI Europe injects public health perspective into European Research and Innovation Framework

20 May

Statement on conflicts of interest delivered at WHA on behalf of HAI, Berne Declaration, KEI, TWN, PHM, IBFAN

17 May

Conflicts of Interest and the Future of Financing for WHO.

10 May

DG Trade public hearing on the “Protection and enforcement of IPR in third countries

29 April

EU-Mercosur Trade Negotiations: What Fate for Access to medicines?